Know Cancer

forgot password

Predicting DVT Risk in GI Cancer Patients Using Plasma Biomarkers

18 Years
Open (Enrolling)
Pancreatic Cancer, Gastrointestinal Neoplasms, Colon Rectal Cancer Adenocarcinoma, Esophageal Cancer, Gall Bladder Cancer, Gastric (Stomach) Cancer, Gastrooesophageal Cancer, Gastrointestinal Stromal Tumor (GIST), Hepatobiliary Neoplasm, Liver Carcinoma, Gallbladder Carcinoma, Bile Duct Carcinoma, Carcinoma of the Large Intestine, Anal Cancer

Thank you

Trial Information

Predicting DVT Risk in GI Cancer Patients Using Plasma Biomarkers

Inclusion Criteria:

- Male or female, >= 18 years old. There are no ethnic restrictions.

- Active cancers of the GI tract (gastroesophageal, colorectal, or pancreatic-biliary)
that have completed TNM staging by the American Joint Committee on Cancer; stage III
disease if diagnosed within 2 months and all stage IV disease

- Ability to understand and the willingness to sign a written informed consent

- Existing staging CT imaging study

Exclusion Criteria:

- Life expectancy < 6 months

- History of deep vein thrombosis (DVT) or pulmonary embolism (PE)

- Known pregnancy or positive urine pregnancy test in pre-menopausal women

- On anticoagulant therapy (heparin, warfarin, direct thrombin inhibitors)

- No CT imaging studies, or contraindications to undergoing CT imaging

- Existing or anticipated need for a tunneled central venous catheter

- Clinic visitation to Stanford Cancer center for secondary consultation purposes only

- Inability to give informed consent

Type of Study:


Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Identify Biomarkers

Outcome Time Frame:

3 years

Safety Issue:


Principal Investigator

Haruka Itakura

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University


United States: Institutional Review Board

Study ID:




Start Date:

August 2008

Completion Date:

December 2015

Related Keywords:

  • Pancreatic Cancer
  • Gastrointestinal Neoplasms
  • Colon Rectal Cancer Adenocarcinoma
  • Esophageal Cancer
  • Gall Bladder Cancer
  • Gastric (Stomach) Cancer
  • Gastrooesophageal Cancer
  • Gastrointestinal Stromal Tumor (GIST)
  • Hepatobiliary Neoplasm
  • Liver Carcinoma
  • Gallbladder Carcinoma
  • Bile Duct Carcinoma
  • Carcinoma of the Large Intestine
  • Anal Cancer
  • Adenocarcinoma
  • Adenocarcinoma, Mucinous
  • Anus Neoplasms
  • Urinary Bladder Neoplasms
  • Neoplasms
  • Carcinoma
  • Rectal Neoplasms
  • Colorectal Neoplasms
  • Esophageal Diseases
  • Esophageal Neoplasms
  • Gastrointestinal Neoplasms
  • Digestive System Neoplasms
  • Pancreatic Neoplasms
  • Gallbladder Neoplasms
  • Gastrointestinal Stromal Tumors
  • Bile Duct Neoplasms
  • Carcinoma, Ductal, Breast
  • Carcinoma, Ductal
  • Carcinoma, Hepatocellular



Stanford University School of Medicine Stanford, California  94305-5317